This bill, known as the "Joe Fiandra Access to Home Infusion Act of 2025," aims to expand Medicare coverage for external infusion pumps and associated non-self-administrable home infusion drugs and supplies. It amends the Social Security Act to ensure these items are covered for home use, even if they don't strictly meet existing durable medical equipment requirements, provided specific conditions are met. For coverage, the drug's FDA-approved prescribing information must require administration by or under the supervision of a healthcare professional . Additionally, a qualified home infusion therapy supplier must administer or supervise the drug in the patient's home, and the drug must be prescribed for infusion at least 12 times annually, either intravenously/subcutaneously or at rates necessitating an external infusion pump. The bill further directs the Secretary of Health and Human Services to ensure patients receive clear notifications about the cost sharing associated with electing home infusion therapy, allowing them to compare it with costs in other applicable care settings under Medicare.